BYOT:LSE-Byotrol plc (GBX)

COMMON STOCK | Household & Personal Products | LSE

Last Closing Price

GBX 6.38

Change

+0.18 (+2.82)%

Market Cap

GBX 0.03B

Volume

0.47M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Byotrol plc develops and commercializes infection control and prevention products in the United Kingdom, North America, and internationally. It operates through Professional and Consumer segments. The company offers hand sanitizers, sanitizing wipes, surface sanitizers, medical device cleaning, and disinfection products; and disinfectant for animal welfare and chlorine tablets. It also provides skin disinfection products, instrument and equipment cleaner products, animal scent absorber, odour control products, wall dispensers, and chemical mixing station. It serves human and animal health, facilities management, food and beverage sectors, as well as household, skincare, and pet care markets. Byotrol plc was incorporated in 2005 and is based in Chester, the United Kingdom. Address: Building 303 (Ashton), Chester, United Kingdom, CH2 4NU

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-01 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ULVR:LSE The Unilever Group

-137.00 (-3.00%)

GBX120.01B 18.15 12.25
RB:LSE Reckitt Benckiser Group plc

-136.00 (-2.07%)

GBX46.37B 19.78 15.05
PZC:LSE PZ Cussons Plc

+1.00 (+0.44%)

GBX0.98B 49.67 17.61
ACRL:LSE Accrol Group Holdings plc

+1.50 (+3.09%)

GBX0.15B N/A 23.39
MCB:LSE McBride plc

-0.80 (-1.20%)

GBX0.12B 18.33 5.89
W7L:LSE Warpaint London PLC

-2.50 (-3.62%)

GBX0.05B 230.00 12.48
CRL:LSE Creightons Plc

+3.00 (+5.88%)

GBX0.03B 11.51 6.51
SKIN:LSE DeepVerge plc

N/A

GBX0.03B N/A N/A
IDP:LSE InnovaDerma PLC

-3.50 (-5.26%)

GBX9.64M 8.21 5.12

ETFs Containing BYOT

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 280.60% 100% A+ 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 280.60% 100% A+ 98% A+
Trailing 12 Months  
Capital Gain 277.22% 100% A+ 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 277.22% 100% A+ 98% A+
Trailing 5 Years  
Capital Gain 98.59% 83% B 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 98.59% 67% D+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 14.36% N/A N/A 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.36% N/A N/A 74% C
Risk Return Profile  
Volatility (Standard Deviation) 73.34% N/A N/A 15% F
Risk Adjusted Return 19.57% N/A N/A 41% F
Market Capitalization 0.03B 22% F 24% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 60.00 25% F 12% F
Price/Book Ratio 3.77 33% F 20% F
Price / Cash Flow Ratio -58.18 100% A+ 94% A
EV/EBITDA 43.52 11% F 9% F
Management Effectiveness  
Return on Equity 4.96% 67% D+ 63% D
Return on Invested Capital -0.58% 22% F 34% F
Return on Assets -2.44% 11% F 32% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta -0.46 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.